Quince Therapeutics
QNCX
#9114
Rank
NZ$0.13 B
Marketcap
$3.15
Share price
1.14%
Change (1 day)
75.53%
Change (1 year)

Earnings for Quince Therapeutics (QNCX)

Earnings in 2024 (TTM): -NZ$55.71 Million

According to Quince Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$47.94 Million, an increase over its 2022 earnings that were of -NZ$90.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quince Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$55.71 Million16.21%
2023 -NZ$47.94 Million-47.15%
2022 -NZ$90.7 Million-43.27%
2021 -NZ$0.16 Billion17.53%
2020 -NZ$0.14 Billion99.1%
2019 -NZ$68.33 Million235.08%
2018 -NZ$20.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 291.68%๐Ÿ‡บ๐Ÿ‡ธ USA